Advising faculty |
|
|
|
Name | Research focus | Phone | |
We are combining top-down and bottom-up approaches to synthetic biology; we use tools of protein engineering and molecular biology, together with novel synthetic cell technologies, to understand and modulate biological processes in complex systems. | 612-625-9066 | ||
We study the genetics of complex traits: how variation in genome sequences influences individual molecular, cellular and organismal features. We also seek to understand the evolutionary forces that shape genomic diversity. | 612-301-1243 | ||
T2D is the most common chronic disease affecting human health, affecting more than 347 million individuals worldwide. T2D is a complex disease characterized by pancreatic β-cell failure to make sufficient amounts of insulin in the setting of obesity and insulin resistance in peripheral tissues. The risk for T2D is determined by many factors. Our genetic makeup can predispose us for T2D, and lifestyle can also reduce or exacerbate health risks. But in recent years, our studies and those of others have shown the importance of babies' time in the womb for influencing health over our lifespan. We and others have shown that poor uterine environments can increase the risk of many diseases in adulthood, including diabetes. Therefore, the long-term goal of the Alejandro Lab is to stop the vicious cycle of diabetes by launching a two-pronged research program for both intervention and prevention of this disease: 1. Research program in the pancreas to promote healthy β-cell: The role of OGT in pancreatic β-cell development and function, and 2. Research program in the placenta to identify modifiable risk factors for T2D: Role of placental nutrient sensor proteins in the developmental programming of pancreatic β-cell dysfunction and susceptibility to T2D. | 612-625-5149 | ||
Transcriptional regulation in cancer and development | 612-626-7028 | ||
| Transplant immune responses/therapy and use of induced pluripotent stem cells | 612-626-2734 | ||
Population, evolutionary, and medical genomics; understanding how human genetic variation affects phenotypic diversity and complex disease; computational genomics and metagenomics | 612-624-4092 | ||
Cell adhesion, signal transduction, cytoskeleton, and C. elegans. | 612-625-1299 | ||
Yeast and Human Cell Cycle Control | 612-624-3442 | ||
Clathrin-mediated endocytosis; mammalian intracellular membrane trafficking. | 612-625-3707 | ||
Structure, assembly and dynamics of actin-based cytoskeletal network | 612-624-3195 | ||
| Focuses on the role of the androgen receptor (AR) and alterations in AR signaling in prostate cancer development and progression | dehm@umn.edu | 612-625-1504 | |
The research in the Engelhart laboratory is directed towards better understanding nucleic acid folding and function in order to advance two broad themes: 1) the development of novel nucleic acid-based imaging, analytical, and diagnostic technologies and 2) the elucidation of unanticipated roles for nucleic acids in vivo. | 612-625-1950 | ||
Molecular Basis of Muscular Dystrophy; Role of Actin in Cell Polarity | 612-626-6517 | ||
Signal transduction and lymphocyte development | 612-625-0401 | ||
Cytoskeleton and Cell Motility, developmental mechanisms, neuroscience, and regulation of gene expression | 612-625-6158 | ||
Chromatin mechanics and dynamics; Quantitative fluorescence microscopy | 612-626-6760 | ||
Regenerative medicine, cardiogenesis, and stem-cell biology. | 612-625-8988 | ||
Fundamental and fascinating developmental processes of meiosis and fertilization using C. elegans | 612-624-3955 | ||
How Rb/E2F1 mediated apoptosis is regulated in normal and cancer cells | 612-626-2905 | ||
The causes and consequences of programmed mutagenesis | 612-624-0457 | ||
Cytoskeleton and cell motility, developmental mechanisms | 612-626-2949 | ||
Molecular mechanism of cell-fate determination in T cells | 612-625-1616 | ||
Kidney development, transcriptional regulation, microRNAs, primary cilia, polycystic kidney disease (PKD) | 612-625-3654 | ||
Development, homeostasis and trafficking of T lymphocytes | 612-625-1496 | ||
| Junge, Harald | Retina, neurovascular interactions, wnt signaling | junge@umn.edu | 612-624-6017 |
Understanding the molecular and genetic mechanisms of vertebrate limb development and apply the study to elucidate the mechanisms of congenital limb in human and limb regeneration | 612-626-9935 | ||
Nuclear reprogramming in somatic cell nuclear cloning and stem cells | 612-624-0498 | ||
Our computational microbiology lab develops methods that bring precision medicine to the microbiome. We apply those methods to find patterns in microbial communities that predict and diagnose human diseases, and we use those patterns to develop novel therapeutics and diagnostics. |
| ||
Cell cycle regulation, Ubiquitination and proteolysis, Genetic mechanisms of tumorigenesis | 612-624-4201 | ||
Stem Cell Biology: regulatory pathways, diseases and therapies Transcriptional control of mesoderm development | 612-626-5869 | ||
Identification and understanding of genes involved in cancer development | 612-626-4979 | ||
Focus on signaling and transcriptional mechanisms that regulate osteoclast differentiation | 612-626-5582 | ||
Cell and molecular biology of HIV and HTLV | 612-626-5525 | ||
Gene therapy for genetic disease and cancer using viral and non-viral vectors | 612-626-1497 | ||
Craniofacial muscles in health and disease | 612-626-0777 | ||
Integrative systems biology of cardiovascular function; Cardiac gene therapy; Transgenic models of heart disease; Molecular mechanisms of sarcomere function; Human iPS cell cardiac myocytes | metzgerj@umn.edu | 612-625-8296 | |
My lab works on pediatric cancer genetics, immunotherapy, and gene therapy using cutting edge technologies, including DNA transposons, TALENs, and CRISPR/Cas9. | 612-625-2226 | ||
Computational biology and functional genomics - Machine learning for integrating diverse genomic data to make inferences about biological networks | 612-624-8306 | ||
Molecular and genetic analysis of Drosophila development | 612-625-1727 | ||
Developmental control of growth and cell proliferation in Drosophila | 612-625-5158 | ||
Cell-cell interactions in growth, differentiation, and development | 612-626-0642 | ||
Mechanisms controlling lineage decision and reprogramming, and application to regenerative medicine | 612-625-4984 | ||
Regulation of dynein-based motility | 612-626-1901 | ||
Our group invents and applies protein engineering technologies to study fundamental functional principles of natural and artificial living systems at a cellular level. | 612-625-1180 | ||
Lymphocyte and tumor cell adhesion, migration and signal transduction | 612-626-6849 | ||
Animal development; control of gene expression; chromatin mechanisms | 612-626-5097 | ||
Protein acrobatics - Study of protein function via protein engineering; Focus on cell signaling and motor proteins | 612-301-1537 | ||
My laboratory is interested in understanding the lifecycle of retroviruses and use this information 1) to identify new drug targets for HIV, 2) to develop better vectors for gene therapy and 3) to use these vectors for gene discovery. | 612-625-6988 | ||
My research focuses mainly on the roles of microRNAs in the pathogenesis of non-alcoholic fatty liver disease (NAFLD), obesity, insulin resistance and liver cancer, with the goal to develop novel therapeutic approaches for these disorders. | 612-624-9961 | ||
Understanding the genetics of cancer in order to develop individualized, targeted therapies | 612-626-6971 | ||
Molecular genetic analysis of unconventional myosin function | 612-625-8498 | ||
Stem cell gene therapy | 612-626-5501 | ||
Role of cardiac progenitor cells in vivo during cardiac development | 612-626-1853 | ||
Cancer transgenic mouse models and pharmacogenomics | 612-624-9944 | ||
Plant genome engineering through homologous recombination; Retrotransposable elements and genome organization | 612-626-4509 | ||
Evaluate retroviral-mediated gene transfer in hematopoietic cells and reversal of the disease process in vitro thus providing the impetus to initiate clinical trials of gene therapy | 612-625-7422 | ||
Cancer gene-therapy and virotherapy | 612-624-9131 | ||
Molecular genetics of sexual differentiation, germ cell development, and testis cancer | 612-625-9450 | ||
Academic faculty |
|
|
|
Name | Research focus | Phone | |
Structure and function of membrane-bound transport proteins | 612-624-3053 | ||
C. albicans genetics and pathogenesis | 612-624-1912 | ||
Transposons, human gene therapy, vertebrate gene expression, mouse, zebrafish | 612-624-6736 | ||
Cytogenetic techniques to elucidate constitutional and acquired chromosome abnormalities | 612-273-4952 | ||
The role of DNA repair and recombination in maintaining genome stability | 612-624-9244 | ||
Human Genetics | 612-626-4521 | ||
Axon guidance and growth cone motility | 612-626-2399 | ||
Chromatin, Genome Instability, DNA Repair, Repetitive DNA Sequences, Bioinformatics | 612-625-6201 | ||
Stem cells for therapeutic retinal cell replacement and progenitor cell maturation in retinal development | 612-624-9182 | ||
Mammalian brain development, cell type specification and establishment of neuronal connectivity | 612-626-4916 | ||
Mechanisms by which cells grow and divide |
| ||
Function of O-GlcNAc protein modification in growth and development, molecular genetics of plant DNA viruses | 612-625-3129 | ||
Developmental timing in C. elegans: from microRNAs to nutritional cues | 612-624-4708 | ||
Desiccation stress, viable but non-culturable cells, biofilms, mRNA stability, plant-pathogen interactions | 612-624-6275 | ||
Uses the laboratory mouse as a model to understand a causative link between chromosome instability and cancer | 612-626-7830 | ||
Discovery and validation of biomarkers for ovarian cancer | 612-625-5920 | ||
Non-viral gene therapy using nanocapsules and the Sleeping Beauty (SB) transposon; antiapoptosis of neurodegenerative disorders using ursodeoxycholic acid as a therapeutic drug; genomic methylation changes associated with transposition of SB; and induced by microRNAs | 612-625-8999 |